Incidence rate of venous thrombosis in women switching combined oral contraceptives: a cohort study
CONCLUSION: Switchers, particularly in the first 3 months after switching, may experience a renewed starter effect thereby increasing the risk of VT.PMID:38694836 | PMC:PMC11060944 | DOI:10.1016/j.rpth.2024.102390 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - May 2, 2024 Category: Hematology Authors: Deeksha Khialani Esther de Rooij Szimonetta Komj áthiné Szépligeti Elena Dudukina Saskia le Cessie Vera Ehrenstein Frits R Rosendaal Astrid van Hylckama Vlieg Source Type: research
Anticoagulation and vascular anomalies
Res Pract Thromb Haemost. 2024 Apr 3;8(3):102402. doi: 10.1016/j.rpth.2024.102402. eCollection 2024 Mar.ABSTRACTA State of the Art lecture titled "Anticoagulation and Vascular Anomalies" was presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress in 2023. Vascular anomalies have been classified by the International Society for the Study of Vascular Anomalies into vascular tumors and vascular malformations. Although some vascular tumors, such as tufted angioma and kaposiform hemangioendothelioma, and other vascular malformations can present with coagulation aberrancies, these are not generally m...
Source: Thrombosis and Haemostasis - May 2, 2024 Category: Hematology Authors: Shelley E Crary Joana M Mack Source Type: research
Patient counseling for pulmonary embolism requires an individualized approach
Res Pract Thromb Haemost. 2024 Apr 12;8(3):102407. doi: 10.1016/j.rpth.2024.102407. eCollection 2024 Mar.NO ABSTRACTPMID:38694838 | PMC:PMC11060943 | DOI:10.1016/j.rpth.2024.102407 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - May 2, 2024 Category: Hematology Authors: Carolyn G Chatterton Lina A Fouad Jeffrey A Kline Source Type: research
Plantar vein thrombosis: 17-year longitudinal study of consecutive patients from a Swiss academic center
CONCLUSION: We provided initial information on the clinical characteristics, treatment, and course of PVT, which partly resembles that of distal deep vein thrombosis.PMID:38694839 | PMC:PMC11061322 | DOI:10.1016/j.rpth.2024.102396 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - May 2, 2024 Category: Hematology Authors: Margarita Serifi Philippe A Kaufmann Riccardo M Fumagalli Adrian Kobe Nils Kucher Stefano Barco Source Type: research
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B
CONCLUSION: PK-guided dosing was reliable according to post hoc analyses, based on low absolute errors that were regarded as clinically irrelevant in most cases. The predefined predictive performance was achieved in mid and peak factor levels but not in trough factor levels due to measurement inaccuracy. PK guidance also seemed feasible.PMID:38689619 | PMC:PMC11058079 | DOI:10.1016/j.rpth.2024.102397 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - May 1, 2024 Category: Hematology Authors: Tine M H J Goedhart Laura H Bukkems Anne-Fleur Zwagemaker Michiel Coppens Karin Fijnvandraat Saskia E M Schols Roger E G Schutgens Jeroen Eikenboom Floor C J I Heubel-Moenen Paula F Ypma Laurens Nieuwenhuizen Karina Meijer Frank W G Leebeek Ron A A Math à Source Type: research
Navigating the challenges: a case report on managing a complicated postpartum course in type 3 von Willebrand disease with alloantibodies
CONCLUSION: The current case emphasizes the postpartum clinical challenges of patients with type 3 VWD and alloantibodies. It underscores the potential role of emicizumab in maintaining hemostatic control.PMID:38689620 | PMC:PMC11058073 | DOI:10.1016/j.rpth.2024.102399 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - May 1, 2024 Category: Hematology Authors: Konrad van der Zwet Karin P M van Galen Annemiek C C Evers Kathelijn Fischer Roger E G Schutgens Lize F D van Vulpen Source Type: research
Corrigendum to Contractility defects hinder glycoprotein VI-mediated platelet activation and affect platelet functions beyond clot contraction [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 1, January 2024, 102322]
Res Pract Thromb Haemost. 2024 Apr 22;8(3):102414. doi: 10.1016/j.rpth.2024.102414. eCollection 2024 Mar.ABSTRACT[This corrects the article DOI: 10.1016/j.rpth.2024.102322.].PMID:38680968 | PMC:PMC11053318 | DOI:10.1016/j.rpth.2024.102414 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - April 29, 2024 Category: Hematology Authors: Martin Kenny Alice Y Pollitt Smita Patil Dishon W Hiebner Albert Smolenski Natalija Lakic Robert Fisher Reema Alsufyani Sebastian Lickert Viola Vogel Ingmar Schoen Source Type: research
Thrombin generation profile using ST-Genesia after PEG-asparaginase in pediatric patients with acute lymphoblastic leukemia
CONCLUSIONS: TGT could be a biomarker of a high VTE risk in ALL pediatric patients. Patients > 10 years, of non-O blood group and with inherited thrombophilia were associated with a significantly higher thrombotic profile, and an increased profile was also observed after administration of PEG-ASP.PMID:38684189 | DOI:10.1055/a-2316-4547 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - April 29, 2024 Category: Hematology Authors: Anna Ruiz-Llobet Susanna Gassiot Edurne Sarrate Josune Zubicaray Susana Rives Warda Suleman Ruben Berrueco Source Type: research
Edoxaban, Rivaroxaban or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2
CONCLUSIONS: The risks of recurrent VTE and all-cause death did not differ significantly among the different DOACs ; however, the risk of bleeding events could differ, with a potentially lower risk of bleeding with rivaroxaban.PMID:38684190 | DOI:10.1055/a-2316-5269 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - April 29, 2024 Category: Hematology Authors: Daisuke Sueta Yugo Yamashita Takeshi Morimoto Ryuki Chatani Yuji Nishimoto Kazuhisa Kaneda Nobutaka Ikeda Yohei Kobayashi Satoshi Ikeda Kitae Kim Moriaki Inoko Toru Takase Shuhei Tsuji Maki Oi Takuma Takeda Kazunori Otsui Jiro Sakamoto Yoshito Ogihara Tak Source Type: research
Whole Blood Viscosity and Thromboembolic Events in Hospitalized Patients with COVID-19: Post hoc Analysis of the ATTACC/ACTIV-4a Trial
Thromb Haemost. 2024 Apr 16. doi: 10.1055/s-0044-1786030. Online ahead of print.NO ABSTRACTPMID:38684221 | DOI:10.1055/s-0044-1786030 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - April 29, 2024 Category: Hematology Authors: Daein Choi Joshua D Froess Patrick R Lawler Mathew D Neal Ryan Zarychanski Robert S Rosenson ATTACC ACTIV-4a Investigators Source Type: research
Corrigendum to Contractility defects hinder glycoprotein VI-mediated platelet activation and affect platelet functions beyond clot contraction [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 1, January 2024, 102322]
Res Pract Thromb Haemost. 2024 Apr 22;8(3):102414. doi: 10.1016/j.rpth.2024.102414. eCollection 2024 Mar.ABSTRACT[This corrects the article DOI: 10.1016/j.rpth.2024.102322.].PMID:38680968 | PMC:PMC11053318 | DOI:10.1016/j.rpth.2024.102414 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - April 29, 2024 Category: Hematology Authors: Martin Kenny Alice Y Pollitt Smita Patil Dishon W Hiebner Albert Smolenski Natalija Lakic Robert Fisher Reema Alsufyani Sebastian Lickert Viola Vogel Ingmar Schoen Source Type: research
Thrombin generation profile using ST-Genesia after PEG-asparaginase in pediatric patients with acute lymphoblastic leukemia
CONCLUSIONS: TGT could be a biomarker of a high VTE risk in ALL pediatric patients. Patients > 10 years, of non-O blood group and with inherited thrombophilia were associated with a significantly higher thrombotic profile, and an increased profile was also observed after administration of PEG-ASP.PMID:38684189 | DOI:10.1055/a-2316-4547 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - April 29, 2024 Category: Hematology Authors: Anna Ruiz-Llobet Susanna Gassiot Edurne Sarrate Josune Zubicaray Susana Rives Warda Suleman Ruben Berrueco Source Type: research
Edoxaban, Rivaroxaban or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2
CONCLUSIONS: The risks of recurrent VTE and all-cause death did not differ significantly among the different DOACs ; however, the risk of bleeding events could differ, with a potentially lower risk of bleeding with rivaroxaban.PMID:38684190 | DOI:10.1055/a-2316-5269 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - April 29, 2024 Category: Hematology Authors: Daisuke Sueta Yugo Yamashita Takeshi Morimoto Ryuki Chatani Yuji Nishimoto Kazuhisa Kaneda Nobutaka Ikeda Yohei Kobayashi Satoshi Ikeda Kitae Kim Moriaki Inoko Toru Takase Shuhei Tsuji Maki Oi Takuma Takeda Kazunori Otsui Jiro Sakamoto Yoshito Ogihara Tak Source Type: research
Whole Blood Viscosity and Thromboembolic Events in Hospitalized Patients with COVID-19: Post hoc Analysis of the ATTACC/ACTIV-4a Trial
Thromb Haemost. 2024 Apr 16. doi: 10.1055/s-0044-1786030. Online ahead of print.NO ABSTRACTPMID:38684221 | DOI:10.1055/s-0044-1786030 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - April 29, 2024 Category: Hematology Authors: Daein Choi Joshua D Froess Patrick R Lawler Mathew D Neal Ryan Zarychanski Robert S Rosenson ATTACC ACTIV-4a Investigators Source Type: research
Corrigendum to Contractility defects hinder glycoprotein VI-mediated platelet activation and affect platelet functions beyond clot contraction [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 1, January 2024, 102322]
Res Pract Thromb Haemost. 2024 Apr 22;8(3):102414. doi: 10.1016/j.rpth.2024.102414. eCollection 2024 Mar.ABSTRACT[This corrects the article DOI: 10.1016/j.rpth.2024.102322.].PMID:38680968 | PMC:PMC11053318 | DOI:10.1016/j.rpth.2024.102414 (Source: Thrombosis and Haemostasis)
Source: Thrombosis and Haemostasis - April 29, 2024 Category: Hematology Authors: Martin Kenny Alice Y Pollitt Smita Patil Dishon W Hiebner Albert Smolenski Natalija Lakic Robert Fisher Reema Alsufyani Sebastian Lickert Viola Vogel Ingmar Schoen Source Type: research
